Avigen, Inc. Fires CEO, Stays Neutral on Offer

San Francisco Business Times -- Drug developer Avigen Inc., while firing its CEO and two others officers, said it has stopped merger discussions and will liquidate if board nominees from its largest shareholders are not elected Friday.

MORE ON THIS TOPIC